aXichem AB (FRA:A6X) ROCE %: -20.19% (As of Mar. 2026)


FRA:A6X aXichem AB FRA:A6X
50 GF Score
Price €0.11
GF Value €0.22
View Full Analysis

What is aXichem AB ROCE %?

aXichem AB FRA:A6X +5.34% 50 ROCE % is -20.19% as of Mar. 2026. GuruFocus rates FRA:A6X with a GF Score™ of 50/100 and a GF Value™ of €0.22.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. aXichem AB's annualized ROCE % for the quarter that ended in Mar. 2026 was -20.19%.

aXichem AB  (FRA:A6X) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

aXichem AB ROCE % Related Terms

aXichem AB ROCE % Historical Data

* Premium members only.

The historical data trend for aXichem AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

aXichem AB ROCE % Chart

aXichem AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -27.26 -28.92 -38.67 -26.37 -29.33

aXichem AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -35.81 -21.65 -20.33 -37.64 -20.19
FRA:A6X
50GF Score
aXichem AB FRA:A6X
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

aXichem AB ROCE % Calculation

aXichem AB's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-1.607/( ( (6.458 - 0.359) + (5.614 - 0.755) )/ 2 )
=-1.607/( (6.099+4.859)/ 2 )
=-1.607/5.479
=-29.33 %

aXichem AB's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-1.048/( ( (5.614 - 0.755) + (5.919 - 0.399) )/ 2 )
=-1.048/( ( 4.859 + 5.52 )/ 2 )
=-1.048/5.1895
=-20.19 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -20.19% mean?
aXichem AB (FRA:A6X) has a ROCE % of -20.19% as of Mar. 2026.
Is aXichem AB's ROCE % too high?
aXichem AB's current ROCE % is -20.19%. Overall, aXichem AB has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's ROCE % compare to LIN and SHW?
aXichem AB's ROCE % of -20.19% can be compared against companies in the Chemicals industry. The industry median ROCE % is 6.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Chemicals company?
The median ROCE % among Chemicals companies is 6.42, based on 1,590 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median ROCE % is 6.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aXichem AB's current ROCE % is -20.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
aXichem AB (FRA:A6X) has a current ROCE % of -20.19%. The stock's GF Value™ is €0.22, compared to a current price of €0.11 — trading 50.7% below its estimated fair value. The current ROCE % is -20.19%. aXichem AB's overall GF Score™ is 50/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For aXichem AB (FRA:A6X), the current ROCE % is -20.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is aXichem AB (FRA:A6X) Overvalued in 2026?

Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued. The current stock price of €0.11 is trading 50.7% below its estimated GF Value™ of €0.22.

Key valuation signals for FRA:A6X:

  • ROCE %: -20.19%
  • GF Value™: €0.22 vs. price of €0.11 (50.7% below fair value)
  • GF Score™: 50/100

No single metric tells the full story. See the FRA:A6X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

aXichem AB Business Description

Other Exchanges AXIC A:Sweden
Address Sodergatan 26, Malmo, NOR, 211 34
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
50GF Score

Get the complete analysis for FRA:A6X

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.11
Price
€0.22
GF Value